InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,734.40
(
0.00%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
77.52
(
0.06%
)
Bitcoin
64,234.82
(
2.20%
)
Post# of 43396
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

tscott4

Send PM Follow Ignore
Followers 11
Posts 586
Boards Moderated 0
Alias Born 08/31/2020

tscott4

Re: nelskof post# 22457

Thursday, 12/10/2020 11:21:26 AM

Thursday, December 10, 2020 11:21:26 AM

Post# of 43396
The number one focus in Durrant and Humanigen is to FILL trials. It’s not stock price at this time. It shows great confidence in Lenzilumab. They need to focus more on advertising to recruit patients and pushing Mayo Clinic to help push drug to fill trials. I could care less about pointless PRs. It is frustrating at times. But you can’t rush it as we see vaccine issues arising
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up